Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis

E-ISSN： 1545-5017|62|5|798-806

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.62, Iss.5, 2015-05, pp. : 798-806

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 612-622

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies

Oncology, Vol. 88, Iss. 1, 2014-09 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1102-1107

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outpatient Pediatric Dermatologic Surgery: Experience in 296 Patients

PEDIATRIC DERMATOLOGY, Vol. 32, Iss. 3, 2015-05 ,pp. : 424-426

John Wiley & Sons Inc

Access to resources Recommend Favorite

Disclosing Adverse Events to Patients

By Cantor Michael D. Barach Paul Derse Arthur Maklan Claire W. Wlody Ginger Schafer Fox Ellen

Joint Commission Journal on Quality and Patient Safety, Vol. 31, Iss. 1, 2005-01 ,pp. : 5-12

Joint Commission Resources

Access to resources Recommend Favorite